Sanofi and Regeneron’s Dupixent has notched another indication in the EU, this time for a common lung disease, marking the first-ever targeted therapy for the …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted
Initiated before hospital admission in advanced trauma systems, tranexamic acid provided an early survival benefit that ultimately failed to translate into favorable 6-month outcomes in
More than 60 years ago, policymakers in Colorado embraced the idea that early intervention could prevent child abuse and save lives.